Final Agenda and Conference Updates

11 views
Skip to first unread message

Cancer Informatics

unread,
Oct 10, 2019, 4:58:33 PM10/10/19
to Cancer Informatics
Ci4CC'ers,

One of our most popular symposiums is just around the corner !  We are looking forward to seeing everyone next week in Napa. 

NOTE:  We are keeping track of the high wind Red Flag announcements effecting in Napa County.  Thus far all is clear for our meeting starting on Monday.

The latest agenda is available online.  Download it here.  Any updates will be announced over the next few days.

Safe travels ! 

Team Ci4CC

Parkin, Heather

unread,
Oct 11, 2019, 1:44:42 AM10/11/19
to cancer-in...@googlegroups.com
Dear CI4CC 
Just a quick question- I haven’t received a delegate pass - do I pick it up on Monday at the conference centre?
Thank you
Heather Parkin 

--
-- You received this message because you are subscribed to the Google Groups Cancer Informatics national academic consortium. To post to this group, send email to cancer-in...@googlegroups.com. To unsubscribe from this group, send email to ci...@ci4cc.org, with the subject line "Unsubscribe". For more options, visit this group at https://groups.google.com/d/forum/cancer-informatics?hl=en
---
You received this message because you are subscribed to the Google Groups "Cancer Informatics" group.
To unsubscribe from this group and stop receiving emails from it, send an email to cancer-informat...@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/cancer-informatics/6dd35cf5-b1b1-47fa-b60f-fb4b93034e5e%40googlegroups.com.
--

Heather Parkin

Strategic Initiatives Lead
Future Place Directorate

Phone:  +44 (0)7500572582
Mail to:  heather.p...@roche.com 

Roche Products Limited 
6 Falcon Way, Shire Park 
Welwyn Garden City 
Hertfordshire 
AL7 1TW

Registered in England No. 100674 


Please consider the environment before printing this email.

Confidentiality Note: The information transmitted in this message is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material.  Any review, re-transmission, dissemination or other use of, or taking of any action in reliance upon, this information by person or persons or entities other than the intended recipient is prohibited.  If you receive this message in error, please contact the sender and delete the material from any computer

Reply all
Reply to author
Forward
0 new messages